Sonus Pharmaceuticals' Stockholders Approve Business Combination With OncoGenex Technologies
August 20, 2008 06:00 ET
|
OncoGenex Pharmaceuticals, Inc.
Stockholders Approve Name Change to OncoGenex Pharmaceuticals, Inc.,
and One-for-Eighteen Reverse Stock Split
Sonus Pharmaceuticals Expects to Complete Arrangement With
...
Sonus Pharmaceuticals Sets Date of Special Shareholders' Meeting
August 18, 2008 16:06 ET
|
OncoGenex Pharmaceuticals, Inc.
BOTHELL, Wash., Aug. 18, 2008 (GLOBE NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) announced today that its Board of Directors has set August 19, 2008, as the date of its Special Meeting of...
Sonus Pharmaceuticals Signs Exclusive In-Licensing Agreement With Bayer Healthcare for Caspase Activator Compounds
August 07, 2008 07:30 ET
|
OncoGenex Pharmaceuticals, Inc.
BOTHELL, Wash., Aug. 7, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) announced today that it has signed an exclusive in-licensing agreement with Bayer HealthCare LLC for...
Sonus Pharmaceuticals and OncoGenex Technologies to Merge
May 28, 2008 06:30 ET
|
OncoGenex Pharmaceuticals, Inc.
Combined Company Will Have Three Oncology Products in Clinic
Lead Candidate Targets Hormone Refractory Prostate and Non-Small Cell
Lung Cancers
Conference...
Sonus Pharmaceuticals, Inc. Receives Staff Determination Letter From Nasdaq
May 09, 2008 07:30 ET
|
OncoGenex Pharmaceuticals, Inc.
BOTHELL, Wash., May 9, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it has received a determination letter from The Nasdaq Stock Market ("Nasdaq") dated May...
Sonus Pharmaceuticals Refines Strategic Initiatives
March 25, 2008 07:30 ET
|
OncoGenex Pharmaceuticals, Inc.
Company Focuses on SN2310 and External Initiatives; Ends Internal
Discovery Effort
Cash Burn Further Reduced
BOTHELL, Wash., March 25, 2008...
Sonus Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
March 05, 2008 16:15 ET
|
OncoGenex Pharmaceuticals, Inc.
Company Continues Efforts to Maximize Shareholder Value
Conference Call to be Held Today at 1:30 P.M. PT/4:30 P.M. ET
BOTHELL, Wash., March 5, 2008 (PRIME NEWSWIRE) -- Sonus...
Sonus Pharmaceuticals Announces Fourth Quarter and Year End Results Conference Call and Presentation At WBBA Invest Northwest
February 20, 2008 16:00 ET
|
OncoGenex Pharmaceuticals, Inc.
BOTHELL, Wash., Feb. 20, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS), an oncology drug development company, today announced that it will release financial results for the fourth...
Sonus Pharmaceuticals Reports Third Quarter Financial Results
November 12, 2007 16:00 ET
|
OncoGenex Pharmaceuticals, Inc.
Company Provides Update on Ongoing Operations and
Efforts to Maximize Shareholder Value
$30 Million in Cash Expected at December 31, 2007
Conference Call...
Sonus Pharmaceuticals Announces Receipt of NASDAQ Notification
November 07, 2007 16:30 ET
|
OncoGenex Pharmaceuticals, Inc.
BOTHELL, Wash., Nov. 7, 2007 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it has received a notice from The Nasdaq Stock Market ("Nasdaq") dated November 5, 2007,...